Related Experiment Video
Updated: Jun 18, 2026
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Eukaryotic transcriptomics in silico: optimizing cDNA-AFLP efficiency.
Kai N Stölting1, Gerrit Gort, Christian Wüst
1Zoological Museum, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. kai.stoelting@access.uzh.ch
BMC Genomics
|December 2, 2009
Summary
Optimizing complementary-DNA based amplified fragment length polymorphism (cDNA-AFLP) assays using in silico simulations across 92 eukaryotic species significantly enhances gene expression profiling efficiency. Enzyme combinations can boost coverage from <40% to 75%, aiding transcriptomic studies.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- Complementary-DNA based amplified fragment length polymorphism (cDNA-AFLP) is vital for linking trait expression to gene activity.
- Optimization studies for cDNA-AFLP assay design are scarce and taxonomically limited.
Purpose of the Study:
- To model cDNA-AFLP across 92 eukaryotic species to optimize assay design.
- To identify optimal restriction enzyme combinations for maximizing cDNA pool coverage.
Main Methods:
- In silico simulations of cDNA-AFLP were performed for 92 eukaryotic species.
- All combinations of eight standard restriction enzymes were tested.
- Phylogenetic signal and GC content effects on coverage were analyzed.
Main Results:
- Optimal enzyme combinations increased cDNA pool coverage from <40% to 75%.
- Organismal GC content influences coverage, but enzyme combination consistency is high across eukaryotes.
- AFLP experiments can estimate the number of expressed genes in a tissue.
Conclusions:
- In silico screening provides guidelines to enhance eukaryotic cDNA-AFLP efficiency.
- cDNA-AFLP can be used to estimate the number of transcripts in a tissue, valuable for next-generation sequencing applications.
